An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

In a powerful demonstration of high-level support, the World Health Organization (WHO) today received nearly US$ 700 million ...

The World Health Organization (WHO) has received nearly $700 million in new funding commitments from European countries, foundations and others, and another $300 million in reaffirmed commitments.

European countries and a handful of non-profit groups have committed $700 million (€627.4 million) to fund the World Health ...

Boehringer Ingelheim and Zealand Pharma have kicked ... consultant in metabolic medicine at University College in Dublin in Ireland, who was the principal investigator of the phase 2 trial.

Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma, respectively. Investigator sites are essential for successful ...

Lenders report that default rates on secured loans to UK households increased in Q3 2024 and are expected to increase again ...

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...

GSK has always refuted claims that its discontinued heartburn drug had cancer-causing risks, arguing that expert testimonies ...

Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...